Company Active LTD

Company profile

Optibiotix Limited

UK company 07992608, incorporated on 15 March 2012.

Home - Optibiotix

Optibiotix Limited is a UK company with status Active founded in 2012 based in Yorkshire and the Humber.

Company number
07992608
Incorporated
15 Mar 2012
Companies House status
Active

Company identity

Founded / incorporated
15 March 2012

Company number 07992608

Verify at Companies House
Legal name
OPTIBIOTIX LIMITED
Company type
Private Limited Company
Region
Yorkshire and the Humber
Registered address
INNOVATION CENTRE INNOVATION WAY
HESLINGTON
YORK
YO10 5DG
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Optibiotix Limited
CRN 07992608
2
Direct and ultimate controller Active PLC
Optibiotix Health PLC
CRN 05880755

Company events

Reference milestones and recent Companies House filing stream events.

5 events
14 Feb
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

31 Jan
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

15 Mar
2012

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2012
Funded years
2012, 2013
Age at first award
0 years

Projects

2013 GRD Proof of Market Lead participant

Novel synbiotic to address weight loss

1 Apr 2013 to 31 Jul 2013

Awarded
£24,193
Total cost £40,322

indigenous species and strains of bacteria that make up the human microbiome, providing greater insight into the role of gut microbial flora. This has generated interest in the development of synbiotics to modify the human microbiome to support weight loss as part of a diet and exercise weight-loss program. Obesity has an adverse effect on health, leading...

2012 Vouchers Lead participant

Developing a novel food product for metabolic syndrome

1 Nov 2012 to 31 Mar 2013

Awarded
£5,000
Total cost £5,000

Metabolic syndrome has been described as the world’s biggest public health problems with over 25% of adults in the UK and USA suffering. More than 2.8 m people die each year as a result of metabolic syndrome. Its occurrence is linked to increasing rates of obesity with weight management programs the cornerstone of management of metabolic syndrome. Limitat...

Product types

GRD Proof of Market Vouchers